Trial · NCT06716645
Outcomes33
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 33
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Adjusted Mean Change From Baseline in Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) Total Score | Baseline and up to Day 7 or End of Treatment (EOT) | The modified Intent-To-Treat (mITT) population included all participants who used study product at least once and had data from at least one post baseline QoL questionnaire to support at least one of the primary endpoint assessments. Only those participants with data available at the specified timepoint were analyzed. | score on a scale | LEAST_SQUARES_MEAN |
| PRIMARY | Adjusted Mean Change From Baseline in WURSS-21 Total Symptom Domain Score | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | LEAST_SQUARES_MEAN |
| PRIMARY | Adjusted Mean Change From Baseline in WURSS-21 Total QoL Domain Score | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | LEAST_SQUARES_MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Cough | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | LEAST_SQUARES_MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Runny Nose | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Plugged Nose | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Sneezing | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Sore Throat | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Scratchy Throat | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Hoarseness | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Head Congestion | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Chest Congestion | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Feeling Tired | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Think Clearly | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Sleep Well | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Breathe Easily | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Walk, Climb Stairs, Exercise | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Accomplish Daily Activities | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Work Outside the Home | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
| PRIMARY | Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Work Inside the Home | Baseline and up to Day 7 or EOT | mITT population. Only those participants with data available at the specified timepoint were analyzed. EOT was defined as the day when the participant ceased study involvement because they no longer required relief from their cough/cold symptoms or the participant reached Day 7 (Or their last available questionnaire information). | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06716645/outcomes